LON:BXP - BEXIMCO PHARMAC/S GDR REGS Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started GBX 49.90 -0.10 (-0.20 %) (As of 05/20/2019 04:00 PM ET)Previous CloseGBX 50Today's RangeGBX 48 - GBX 4852-Week RangeGBX 41 - GBX 56.90Volume6,000 shsAverage Volume35,555 shsMarket Capitalization£202.37 millionP/E RatioN/ADividend Yield2.59%BetaN/A ProfileAnalyst RatingsChartHeadlinesOptions Chain Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and active pharmaceutical ingredients in Bangladesh. The company offers allergic disorder, analgesic and antipyretic, anti-infective, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, muscloskeletal, oncology, respiratory, skin care, vitamin and mineral supplement, oral contraceptive, anti-histamine, anti-fibrinolytic, women's health, and other products. It also provides contract manufacturing services. In addition, the company exports its products to approximately 40 countries worldwide. Beximco Pharmaceuticals Limited was founded in 1976 and is headquartered in Dhaka, Bangladesh. Receive BXP News and Ratings via Email Sign-up to receive the latest news and ratings for BXP and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange LON Industry Drug Manufacturers - Major Sub-IndustryN/A SectorMedical Current SymbolLON:BXP Previous Symbol CUSIPN/A CIKN/A Webwww.beximco-pharma.com Phone+880-2-58611001Debt Debt-to-Equity Ratio38.08 Current Ratio1.17 Quick Ratio0.36Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees4,200 Outstanding Shares405,556,000Market Cap£202.37 million Next Earnings DateN/A OptionableOptionable BEXIMCO PHARMAC/S GDR REGS (LON:BXP) Frequently Asked Questions What is BEXIMCO PHARMAC/S GDR REGS's stock symbol? BEXIMCO PHARMAC/S GDR REGS trades on the London Stock Exchange (LON) under the ticker symbol "BXP." What price target have analysts set for BXP? 1 brokerages have issued 12-month target prices for BEXIMCO PHARMAC/S GDR REGS's shares. Their forecasts range from GBX 84 to GBX 84. On average, they expect BEXIMCO PHARMAC/S GDR REGS's stock price to reach GBX 84 in the next year. This suggests a possible upside of 68.3% from the stock's current price. View Analyst Price Targets for BEXIMCO PHARMAC/S GDR REGS. What is the consensus analysts' recommendation for BEXIMCO PHARMAC/S GDR REGS? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BEXIMCO PHARMAC/S GDR REGS in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for BEXIMCO PHARMAC/S GDR REGS. Has BEXIMCO PHARMAC/S GDR REGS been receiving favorable news coverage? News articles about BXP stock have been trending somewhat negative on Monday, InfoTrie Sentiment reports. InfoTrie identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. BEXIMCO PHARMAC/S GDR REGS earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the next few days. Who are some of BEXIMCO PHARMAC/S GDR REGS's key competitors? Some companies that are related to BEXIMCO PHARMAC/S GDR REGS include Vectura Group (VEC), Medical Developments International (MVP), Eco Animal Health Group (EAH), Opthea (OPT), Trilogy International Partners (TRL), Pharmaxis (PXS), Allergy Therapeutics (AGY), Vita Life Sciences (VLS), Futura Medical (FUM), Cathay International (CTI), Patrys (PAB), Avivagen (VIV), Recce Pharmaceuticals (RCE), Antisense Therapeutics (ANP) and NanoViricides (NNVC). Who are BEXIMCO PHARMAC/S GDR REGS's key executives? BEXIMCO PHARMAC/S GDR REGS's management team includes the folowing people: Mr. Nazmul Hassan MP, MD & DirectorMr. Ali Nawaz, Chief Fin. OfficerMr. Rabbur Reza, Chief Operating OfficerMr. Jamal Ahmed Choudhury, Exec. Director of Accounts & Fin.Mr. M. A. Arshad Bhuiyan, Deputy Gen. Mang. of HR How do I buy shares of BEXIMCO PHARMAC/S GDR REGS? Shares of BXP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is BEXIMCO PHARMAC/S GDR REGS's stock price today? One share of BXP stock can currently be purchased for approximately GBX 49.90. How big of a company is BEXIMCO PHARMAC/S GDR REGS? BEXIMCO PHARMAC/S GDR REGS has a market capitalization of £202.37 million. BEXIMCO PHARMAC/S GDR REGS employs 4,200 workers across the globe. What is BEXIMCO PHARMAC/S GDR REGS's official website? The official website for BEXIMCO PHARMAC/S GDR REGS is http://www.beximco-pharma.com/. How can I contact BEXIMCO PHARMAC/S GDR REGS? BEXIMCO PHARMAC/S GDR REGS's mailing address is 19 Dhanmondi R/A, Road No. 7, DHAKA, 1205, Bangladesh. The company can be reached via phone at +880-2-58611001. MarketBeat Community Rating for BEXIMCO PHARMAC/S GDR REGS (LON BXP)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 95 (Vote Outperform)Underperform Votes: 107 (Vote Underperform)Total Votes: 202MarketBeat's community ratings are surveys of what our community members think about BEXIMCO PHARMAC/S GDR REGS and other stocks. Vote "Outperform" if you believe BXP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BXP will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/20/2019 by MarketBeat.com StaffFeatured Article: Quiet Period Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.